| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Gavisconell Liquid Mint | 300 ml | 5.83 | 10.75 | 10 % | | Suspension zum Einnehmen in Flaschen: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D / SL | FB | | G |  |
| | | IP | CI | | Gaviscon Mint | 8 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 8 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Mint | 16 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 16 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 24 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Mint | 32 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 32 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Mint | 48 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 48 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Mint | 64 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Erdbeer | 64 Tablet(s) | PR | PR | k.A. | | Chewing tablets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gavisconell Liquid Mint | 150 ml | PR | PR | k.A. | | Suspension zum Einnehmen in Flaschen: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Liquid Mint | 12 Sachet(s) | PR | PR | k.A. | | Suspension zum Einnehmen in Sachets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Gaviscon Liquid Mint | 24 Sachet(s) | PR | PR | k.A. | | Suspension zum Einnehmen in Sachets: 3 Active Agents | Reckitt Benckiser
(Switzerland) AG | D | FB | | G | |
| | | IP | CI | | Refluxin | 30 Tablet(s) | PR | 9.10 | k.A. | | Tablets: 3 Active Agents | Spirig Pharma AG | D / SO | FB | | G | |
| | | IP | CI | | Refluxin | 150 Tablet(s) | PR | 35.55 | k.A. | | Tablets: 3 Active Agents | Spirig Pharma AG | D / SO | FB | | G | |
| | | IP | CI | | Alumagall | 27 Tablet(s) | PR | 8.95 | k.A. | | Lozenges: 3 Active Agents | Perrigo Schweiz AG | D | FB | | G | |
| | | | | | Magentee H | 110 g | PR | PR | k.A. | | Chopped herbs: 13 Active Agents | Hänseler AG | D | FB | | G | |
| | | | | | Gastrikur | 200 g | PR | 8.50 | k.A. | | Soluble Powder: 3 Active Agents | Pharma-Med AG | D | FB | | G | |
| | | IP | CI | | Magenpulver Hafter AA | 50 g | PR | PR | k.A. | | Soluble Powder: 3 Active Agents | G. Streuli & Co. AG | B | FB | | G | |
| | | IP | CI | | Magenpulver Hafter AA | 100 g | PR | 13.90 | k.A. | | Soluble Powder: 3 Active Agents | G. Streuli & Co. AG | B | FB | | G | |
| | | IP | CI | | Magentabletten Hafter 15
Streuli | 30 Tablet(s) | PR | 7.30 | k.A. | | Tablets: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G | |
| | | | CI | | Gaviscon | 200 ml | PR | 12.90 | k.A. | | Suspension (oral): 4 Active Agents | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | D | FB | | G | |
